Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bürk K[au]:

Friedreich Ataxia: current status and future prospects. Bürk K et al. Cerebellum Ataxias. (2017)

Capture of Dense Core Vesicles at Synapses by JNK-Dependent Phosphorylation of Synaptotagmin-4. Bharat V et al. Cell Rep. (2017)

Imaging and Screening of Pancreatic Cancer. Burk KS et al. Radiol Clin North Am. (2017)

Search results

Items: 1 to 50 of 188

1.

A clinical diagnostic algorithm for early onset cerebellar ataxia.

Brandsma R, Verschuuren-Bemelmans CC, Amrom D, Barisic N, Baxter P, Bertini E, Blumkin L, Brankovic-Sreckovic V, Brouwer OF, Bürk K, Catsman-Berrevoets CE, Craiu D, de Coo IFM, Gburek J, Kennedy C, de Koning TJ, Kremer HPH, Kumar R, Macaya A, Micalizzi A, Mirabelli-Badenier M, Nemeth A, Nuovo S, Poll-The B, Lerman-Sagie T, Steinlin M, Synofzik M, Tijssen MAJ, Vasco G, Willemsen MAAP, Zanni G, Valente EM, Boltshauser E, Sival DA.

Eur J Paediatr Neurol. 2019 Aug 10. pii: S1090-3798(19)30027-3. doi: 10.1016/j.ejpn.2019.08.004. [Epub ahead of print]

PMID:
31481303
2.

Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI.

Sippo DA, Rutledge GM, Mercaldo SF, Burk KS, Edmonds CE, Dang PA, Lehman CD.

Acad Radiol. 2019 Jul 18. pii: S1076-6332(19)30326-5. doi: 10.1016/j.acra.2019.06.020. [Epub ahead of print]

PMID:
31327575
3.

Sensory Axon Growth Requires Spatiotemporal Integration of CaSR and TrkB Signaling.

Markworth R, Adolfs Y, Dambeck V, Steinbeck LM, Lizé M, Pasterkamp RJ, Bähr M, Dean C, Burk K.

J Neurosci. 2019 Jul 24;39(30):5842-5860. doi: 10.1523/JNEUROSCI.0027-19.2019. Epub 2019 May 23.

PMID:
31123102
4.

Diagnostic evaluation and treatment of primary breast osteosarcoma: A case report.

Burk KS, Fang Y, Porembka JH.

Breast J. 2019 Jul;25(4):709-711. doi: 10.1111/tbj.13305. Epub 2019 May 11.

PMID:
31077474
5.

Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications.

Sippo DA, Burk KS, Mercaldo SF, Rutledge GM, Edmonds C, Guan Z, Hughes KS, Lehman CD.

Radiology. 2019 Jul;292(1):51-59. doi: 10.1148/radiol.2019181136. Epub 2019 May 7.

PMID:
31063080
6.

Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.

Sippo DA, Rutledge GM, Burk KS, Mercaldo SF, Dontchos BN, Edmonds CE, Lehman CD.

AJR Am J Roentgenol. 2019 Mar 19:1-7. doi: 10.2214/AJR.18.20566. [Epub ahead of print]

PMID:
30888867
7.

Hepatitis C seroprevalence and engagement in related care and treatment among trans women.

Wilson EC, Turner C, Lin J, McFarland W, Burk K, Raymond HF.

J Viral Hepat. 2019 Jul;26(7):923-925. doi: 10.1111/jvh.13089. Epub 2019 Mar 27. No abstract available.

PMID:
30809884
8.

Evaluation and application of a method for estimating nasal end-tidal O2 fraction while administering supplemental O2.

Burk KM, Kuck K, Orr JA.

J Clin Monit Comput. 2019 Feb 6. doi: 10.1007/s10877-019-00264-5. [Epub ahead of print]

PMID:
30725266
9.

Disrupted neuronal trafficking in amyotrophic lateral sclerosis.

Burk K, Pasterkamp RJ.

Acta Neuropathol. 2019 Jun;137(6):859-877. doi: 10.1007/s00401-019-01964-7. Epub 2019 Feb 5. Review.

10.

Comparing Nasal End-Tidal Carbon Dioxide Measurement Variation and Agreement While Delivering Pulsed and Continuous Flow Oxygen in Volunteers and Patients.

Burk KM, Sakata DJ, Kuck K, Orr JA.

Anesth Analg. 2019 Jan 8. doi: 10.1213/ANE.0000000000004004. [Epub ahead of print]

PMID:
30633057
11.

Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting.

Awasthi A, Ramachandran B, Ahmed S, Benito E, Shinoda Y, Nitzan N, Heukamp A, Rannio S, Martens H, Barth J, Burk K, Wang YT, Fischer A, Dean C.

Science. 2019 Jan 4;363(6422). pii: eaav1483. doi: 10.1126/science.aav1483. Epub 2018 Dec 13.

PMID:
30545844
12.

Cystic Pancreatic Tumors.

Burk KS, Knipp D, Sahani DV.

Magn Reson Imaging Clin N Am. 2018 Aug;26(3):405-420. doi: 10.1016/j.mric.2018.03.006. Review.

PMID:
30376978
13.

Case 30-2018: A 66-Year-Old Woman with Chronic Abdominal Pain.

Rubin AK, Burk KS, Staller K, Kunitake H, Robbins GK, Deshpande V.

N Engl J Med. 2018 Sep 27;379(13):1263-1272. doi: 10.1056/NEJMcpc1802831. No abstract available.

PMID:
30257156
14.

Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).

Reetz K, Dogan I, Hohenfeld C, Didszun C, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, Rodríguez de Rivera Garrido FJ, Schöls L, Giordano I, Bürk K, Pandolfo M, Schulz JB; EFACTS Study Group.

Neurology. 2018 Sep 4;91(10):e917-e930. doi: 10.1212/WNL.0000000000006121. Epub 2018 Aug 10.

PMID:
30097477
15.

[Primary and Secondary Fall Prevention in the Rehabilitation: A Practical Approach to Fall Prevention].

Bujan B, Döring C, Sturzenegger C, Bürk K.

Rehabilitation (Stuttg). 2019 Aug;58(4):269-273. doi: 10.1055/a-0638-8948. Epub 2018 Jul 26. German.

PMID:
30048997
16.

Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF; End Hep C SF.

PLoS One. 2018 Jul 12;13(7):e0200866. doi: 10.1371/journal.pone.0200866. eCollection 2018.

17.

Novel mandibular advancement bite block with supplemental oxygen to both nasal and oral cavity improves oxygenation during esophagogastroduodenoscopy: a bench comparison.

Teng WN, Ting CK, Wang YT, Yang KY, Tsou MY, Orr JA, Burk KM, Chiang H, Lin CL.

J Clin Monit Comput. 2019 Jun;33(3):523-530. doi: 10.1007/s10877-018-0173-9. Epub 2018 Jul 4.

PMID:
29974302
18.

Scales for the clinical evaluation of cerebellar disorders.

Bürk K, Sival DA.

Handb Clin Neurol. 2018;154:329-339. doi: 10.1016/B978-0-444-63956-1.00020-5. Review.

PMID:
29903450
19.

New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care.

Facente SN, Burk K, Eagen K, Mara ES, Smith AA, Lynch CS.

Infect Dis Clin North Am. 2018 Jun;32(2):313-322. doi: 10.1016/j.idc.2018.02.012. Review.

20.

Localized US Efforts to Eliminate Hepatitis C.

Gaudino A, Gay B, Garmon C, Selick M, Vreeland R, Burk K, Huriaux E, Facente SN, Luetkemeyer A, Waters P, Graham CS.

Infect Dis Clin North Am. 2018 Jun;32(2):293-311. doi: 10.1016/j.idc.2018.02.009. Review.

PMID:
29778257
21.

Persistent escalation of alcohol consumption by mice exposed to brief episodes of social defeat stress: suppression by CRF-R1 antagonism.

Newman EL, Albrechet-Souza L, Andrew PM, Auld JG, Burk KC, Hwa LS, Zhang EY, DeBold JF, Miczek KA.

Psychopharmacology (Berl). 2018 Jun;235(6):1807-1820. doi: 10.1007/s00213-018-4905-9. Epub 2018 Apr 25.

22.

Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF; End Hep C SF.

PLoS One. 2018 Apr 11;13(4):e0195575. doi: 10.1371/journal.pone.0195575. eCollection 2018. Erratum in: PLoS One. 2018 Jul 12;13(7):e0200866.

23.

Patient Complaints in Image-Guided Interventions: Evaluation of Multifactorial Issues Using a Coding Taxonomy.

Salazar GM, Burk KS, Abujudeh H.

AJR Am J Roentgenol. 2018 Jun;210(6):1288-1291. doi: 10.2214/AJR.17.19104. Epub 2018 Mar 16.

PMID:
29547056
24.

Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.

Tanguy Melac A, Mariotti C, Filipovic Pierucci A, Giunti P, Arpa J, Boesch S, Klopstock T, Müller Vom Hagen J, Klockgether T, Bürk K, Schulz JB, Reetz K, Pandolfo M, Durr A, Tezenas du Montcel S; EFACTS group.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):559-565. doi: 10.1136/jnnp-2017-316964. Epub 2017 Dec 26.

PMID:
29279305
25.

Capture of Dense Core Vesicles at Synapses by JNK-Dependent Phosphorylation of Synaptotagmin-4.

Bharat V, Siebrecht M, Burk K, Ahmed S, Reissner C, Kohansal-Nodehi M, Steubler V, Zweckstetter M, Ting JT, Dean C.

Cell Rep. 2017 Nov 21;21(8):2118-2133. doi: 10.1016/j.celrep.2017.10.084.

26.

Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.

Canellas R, Burk KS, Parakh A, Sahani DV.

AJR Am J Roentgenol. 2018 Feb;210(2):341-346. doi: 10.2214/AJR.17.18417. Epub 2017 Nov 15.

PMID:
29140113
27.

Imaging and Screening of Pancreatic Cancer.

Burk KS, Lo GC, Gee MS, Sahani DV.

Radiol Clin North Am. 2017 Nov;55(6):1223-1234. doi: 10.1016/j.rcl.2017.06.006. Review.

PMID:
28991562
28.

A Verbal Electronic Checklist for Timeouts Linked to the Electronic Health Record.

Uppot RN, McCarthy CJ, Haynes AB, Burk KS, Mills T, Trifanov DS, Koo TK, Salazar GM, Halpern EF, Yu AY.

J Am Coll Radiol. 2017 Oct;14(10):1322-1325. doi: 10.1016/j.jacr.2017.03.025. Epub 2017 May 24. No abstract available.

PMID:
28551343
29.

EndophilinAs regulate endosomal sorting of BDNF-TrkB to mediate survival signaling in hippocampal neurons.

Burk K, Murdoch JD, Freytag S, Koenig M, Bharat V, Markworth R, Burkhardt S, Fischer A, Dean C.

Sci Rep. 2017 May 19;7(1):2149. doi: 10.1038/s41598-017-02202-4.

30.

Friedreich Ataxia: current status and future prospects.

Bürk K.

Cerebellum Ataxias. 2017 Apr 7;4:4. doi: 10.1186/s40673-017-0062-x. eCollection 2017. Review.

31.

Post-endocytic sorting of Plexin-D1 controls signal transduction and development of axonal and vascular circuits.

Burk K, Mire E, Bellon A, Hocine M, Guillot J, Moraes F, Yoshida Y, Simons M, Chauvet S, Mann F.

Nat Commun. 2017 Feb 22;8:14508. doi: 10.1038/ncomms14508.

32.

Regulation of Dendritic Spine Morphology in Hippocampal Neurons by Copine-6.

Burk K, Ramachandran B, Ahmed S, Hurtado-Zavala JI, Awasthi A, Benito E, Faram R, Ahmad H, Swaminathan A, McIlhinney J, Fischer A, Perestenko P, Dean C.

Cereb Cortex. 2018 Apr 1;28(4):1087-1104. doi: 10.1093/cercor/bhx009.

PMID:
28158493
33.

Interneuronal mechanisms of hippocampal theta oscillations in a full-scale model of the rodent CA1 circuit.

Bezaire MJ, Raikov I, Burk K, Vyas D, Soltesz I.

Elife. 2016 Dec 23;5. pii: e18566. doi: 10.7554/eLife.18566.

34.

Sentürk et al. reply.

Sentürk A, Pfennig S, Weiss A, Burk K, Acker-Palmer A.

Nature. 2016 Nov 24;539(7630):E6-E7. doi: 10.1038/nature20130. No abstract available.

PMID:
27882967
35.

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.

Reetz K, Dogan I, Hilgers RD, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, de Rivera FJR, Schöls L, Klockgether T, Bürk K, Rai M, Pandolfo M, Schulz JB; EFACTS Study Group.

Lancet Neurol. 2016 Dec;15(13):1346-1354. doi: 10.1016/S1474-4422(16)30287-3. Erratum in: Lancet Neurol. 2017 Dec;16(12 ):954.

PMID:
27839651
36.

Relationship and Characteristics of Falling at Temples among the Elderly Group in Nakhon Ratchasima, Thailand.

Horpibulsuk J, Chinkulkijniwat A, Panichpisal K, Burk K.

J Med Assoc Thai. 2016 Oct;99 Suppl 7:S1-7.

PMID:
29901324
37.

Pretransplantation Imaging Workup of the Liver Donor and Recipient.

Burk KS, Singh AK, Vagefi PA, Sahani D.

Radiol Clin North Am. 2016 Mar;54(2):185-97. doi: 10.1016/j.rcl.2015.09.010. Epub 2015 Dec 28. Review.

PMID:
26896219
38.

Spinocerebellar ataxia 28: a novel AFG3L2 mutation in a German family with young onset, slow progression and saccadic slowing.

Zühlke C, Mikat B, Timmann D, Wieczorek D, Gillessen-Kaesbach G, Bürk K.

Cerebellum Ataxias. 2015 Dec 16;2:19. doi: 10.1186/s40673-015-0038-7. eCollection 2015.

39.

No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.

Schöls L, Reimold M, Seidel K, Globas C, Brockmann K, Hauser TK, Auburger G, Bürk K, den Dunnen W, Reischl G, Korf HW, Brunt ER, Rüb U.

Brain. 2015 Nov;138(Pt 11):3316-26. doi: 10.1093/brain/awv255. Epub 2015 Sep 11.

PMID:
26362908
40.

A mainstream monitoring system for respiratory CO2 concentration and gasflow.

Yang J, Chen B, Burk K, Wang H, Zhou J.

J Clin Monit Comput. 2016 Aug;30(4):467-73. doi: 10.1007/s10877-015-9739-y. Epub 2015 Jul 16.

PMID:
26178886
41.

[Parkinson syndromes: aspects of social medical care].

Bujan B, Ginzburg E, Oertel WH, Bürk K.

Rehabilitation (Stuttg). 2015 Apr;54(2):81-5. doi: 10.1055/s-0034-1394444. Epub 2015 Feb 24. German.

PMID:
25710302
42.

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.

Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, Boesch S, Nachbauer W, Klopstock T, Karin I, Depondt C, vom Hagen JM, Schöls L, Giordano IA, Klockgether T, Bürk K, Pandolfo M, Schulz JB.

Lancet Neurol. 2015 Feb;14(2):174-82. doi: 10.1016/S1474-4422(14)70321-7. Epub 2015 Jan 5.

PMID:
25566998
43.

A novel missense mutation in CACNA1A evaluated by in silico protein modeling is associated with non-episodic spinocerebellar ataxia with slow progression.

Bürk K, Kaiser FJ, Tennstedt S, Schöls L, Kreuz FR, Wieland T, Strom TM, Büttner T, Hollstein R, Braunholz D, Plaschke J, Gillessen-Kaesbach G, Zühlke C.

Eur J Med Genet. 2014 Apr;57(5):207-11. doi: 10.1016/j.ejmg.2014.01.005. Epub 2014 Jan 29.

PMID:
24486772
44.

Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales.

Bürk K, Schulz SR, Schulz JB.

J Neurochem. 2013 Aug;126 Suppl 1:118-24. doi: 10.1111/jnc.12318. Review.

45.

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.

Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, Rakowicz M, Sulek A, Durr A, Charles P, Filla A, Antenora A, Schöls L, Schicks J, Infante J, Kang JS, Timmann D, Di Fabio R, Masciullo M, Baliko L, Melegh B, Boesch S, Bürk K, Peltz A, Schulz JB, Dufaure-Garé I, Klockgether T.

Lancet Neurol. 2013 Jul;12(7):650-8. doi: 10.1016/S1474-4422(13)70104-2. Epub 2013 May 22. Erratum in: Lancet Neurol. 2013 Jul;12(7):630.

PMID:
23707147
46.

Navigation rules for vessels and neurons: cooperative signaling between VEGF and neural guidance cues.

Chauvet S, Burk K, Mann F.

Cell Mol Life Sci. 2013 May;70(10):1685-703. doi: 10.1007/s00018-013-1278-4. Epub 2013 Mar 12. Review.

PMID:
23475066
47.

Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2).

Rüb U, Farrag K, Seidel K, Brunt ER, Heinsen H, Bürk K, Melegh B, von Gall C, Auburger G, Bohl J, Korf HW, Hoche F, den Dunnen W.

Neuropathol Appl Neurobiol. 2013 Oct;39(6):634-43. doi: 10.1111/nan.12025.

PMID:
23363055
48.

Multiple system atrophy of the cerebellar type (MSA-C) with concomitant beta-amyloid and tau pathology.

Bujan B, Hofer MJ, Oertel WH, Pagenstecher A, Bürk K.

Clin Neuropathol. 2013 Jul-Aug;32(4):286-90. doi: 10.5414/NP300572.

PMID:
23320996
49.

Mesial temporal lobe epilepsy in a patient with spinocerebellar ataxia type 13 (SCA13).

Bürk K, Strzelczyk A, Reif PS, Figueroa KP, Pulst SM, Zühlke C, Oertel WH, Hamer HM, Rosenow F.

Int J Neurosci. 2013 Apr;123(4):278-82. doi: 10.3109/00207454.2012.755180. Epub 2013 Jan 29.

PMID:
23215817
50.

Agrin-signaling is necessary for the integration of newly generated neurons in the adult olfactory bulb.

Burk K, Desoeuvre A, Boutin C, Smith MA, Kröger S, Bosio A, Tiveron MC, Cremer H.

J Neurosci. 2012 Mar 14;32(11):3759-64. doi: 10.1523/JNEUROSCI.4906-11.2012.

Supplemental Content

Support Center